Aili He

1.4k total citations
73 papers, 1.0k citations indexed

About

Aili He is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Aili He has authored 73 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 39 papers in Hematology and 22 papers in Oncology. Recurrent topics in Aili He's work include Multiple Myeloma Research and Treatments (22 papers), Acute Myeloid Leukemia Research (16 papers) and RNA modifications and cancer (12 papers). Aili He is often cited by papers focused on Multiple Myeloma Research and Treatments (22 papers), Acute Myeloid Leukemia Research (16 papers) and RNA modifications and cancer (12 papers). Aili He collaborates with scholars based in China, United States and Belgium. Aili He's co-authors include Xiaman Wang, Tian Liu, Jing Liu, Ju Bai, Rui Liu, Yuandong Feng, Fangxia Wang, Bo Lei, Hongli Chen and Ying Shen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Aili He

69 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aili He China 17 772 520 189 186 100 73 1.0k
Katja Brocke-Heidrich Germany 8 718 0.9× 551 1.1× 276 1.5× 118 0.6× 221 2.2× 11 1.0k
Natalia Baran United States 15 380 0.5× 204 0.4× 153 0.8× 244 1.3× 101 1.0× 62 679
Simon Bomken United Kingdom 13 376 0.5× 223 0.4× 366 1.9× 234 1.3× 146 1.5× 32 964
Shilpi Arora United States 15 680 0.9× 262 0.5× 260 1.4× 71 0.4× 60 0.6× 31 948
Na Luo China 13 373 0.5× 180 0.3× 115 0.6× 262 1.4× 126 1.3× 22 715
Wenyi Shen China 13 367 0.5× 212 0.4× 91 0.5× 105 0.6× 144 1.4× 55 597
Julianty Frost United Kingdom 7 525 0.7× 217 0.4× 159 0.8× 68 0.4× 115 1.1× 8 731
Beth O. Van Emburgh United States 9 664 0.9× 165 0.3× 223 1.2× 77 0.4× 44 0.4× 10 922
Natalia Liem Singapore 14 566 0.7× 136 0.3× 302 1.6× 168 0.9× 89 0.9× 18 944

Countries citing papers authored by Aili He

Since Specialization
Citations

This map shows the geographic impact of Aili He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aili He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aili He more than expected).

Fields of papers citing papers by Aili He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aili He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aili He. The network helps show where Aili He may publish in the future.

Co-authorship network of co-authors of Aili He

This figure shows the co-authorship network connecting the top 25 collaborators of Aili He. A scholar is included among the top collaborators of Aili He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aili He. Aili He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Rui, Rui Yang, Xuezhu Xu, et al.. (2024). Outcomes in patients with multiple myeloma receiving salvage treatment after BCMA‐specific CAR‐T therapy: A retrospective analysis of LEGEND‐2. British Journal of Haematology. 204(5). 1780–1789. 4 indexed citations
3.
Li, Wen, Rui Liu, Ying Shen, et al.. (2024). Incidence, Risk Factors, and Modified Risk Assessment Model of Venous Thromboembolism in Non‐Hodgkin Lymphoma Patients. Cancer Medicine. 13(24). e70510–e70510. 2 indexed citations
4.
Miao, Jiyu, Ru Zhang, Rui Liu, et al.. (2024). KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway. Journal of Cancer Research and Clinical Oncology. 150(5). 239–239. 3 indexed citations
5.
Liu, Rui, Dandan Gao, Yang Lv, et al.. (2024). Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myeloma. Frontiers in Oncology. 14. 1365460–1365460.
6.
7.
Xiao, Yu, Rui Liu, Dan Yang, et al.. (2023). PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6. Cell Death and Disease. 14(8). 512–512. 23 indexed citations
9.
Liu, Rui, Jiyu Miao, Guangyao Kong, et al.. (2023). N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis-mediated cell cycle transition. Oncogene. 42(20). 1607–1619. 17 indexed citations
10.
Liu, Jing, Jiyu Miao, Fei Hong, et al.. (2023). Circular RNA circXPO1 Promotes Multiple Myeloma Progression by Regulating miR-495-3p/DNA Damage-Induced Transcription 4 Axis. DNA and Cell Biology. 43(1). 39–55. 4 indexed citations
11.
Dietrich, Kevin, Zhenning Wang, Sarah H. O’Brien, et al.. (2023). OC 38.2 Acquired Abnormalities in the Hemostatic System during Induction Chemotherapy in Treatment of Childhood Acute Lymphoblastic Leukemia (ALL): A Biomarker Sub-Study of the PREVAPIX-ALL Trial. Research and Practice in Thrombosis and Haemostasis. 7. 100522–100522. 1 indexed citations
12.
Sun, Chunyan, Guangxun Gao, Fuling Zhou, et al.. (2023). Interim Results of the Launch Study-a Multicenter, Open-Label Study of Selinexor, Dexamethasone and Chemotherapy Drugs in Relapsed/ Refractory Multiple Myeloma. Blood. 142(Supplement 1). 4763–4763. 1 indexed citations
13.
Liu, Rui, et al.. (2022). Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression. Journal of Cancer Research and Clinical Oncology. 148(9). 2215–2230. 7 indexed citations
14.
Hong, Fei, Ming Shi, Jiang Cao, et al.. (2021). Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia. Journal of Cellular and Molecular Medicine. 25(24). 11063–11074. 23 indexed citations
15.
Shen, Ying, Ru Zhang, Hongli Chen, et al.. (2019). Using Circ-ANAPC7 As a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia. Blood. 134(Supplement_1). 5179–5179. 1 indexed citations
16.
Chen, Hongli, Xiaman Wang, Ju Bai, & Aili He. (2017). Expression, regulation and function of miR-495 in healthy and tumor tissues. Oncology Letters. 13(4). 2021–2026. 40 indexed citations
17.
Liu, Jing, Tian Liu, Xiaman Wang, & Aili He. (2017). Circles reshaping the RNA world: from waste to treasure. Molecular Cancer. 16(1). 58–58. 339 indexed citations
18.
He, Aili, Ju Bai, Chen Huang, et al.. (2012). Detection of serum tumor markers in multiple myeloma using the CLINPROT system. International Journal of Hematology. 95(6). 668–674. 16 indexed citations
20.
Zhang, Pengyu, et al.. (2008). Identification and functional characterization of the novel acute monocytic leukemia associated antigen MLAA-34. Cancer Immunology Immunotherapy. 58(2). 281–290. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026